6339138
Last Update Posted: 2024-12-30
Recruiting has ended
All Genders accepted | 18 Years + |
589 Estimated Participants | No Expanded Access |
Observational Study | Accepts healthy volunteers |
Identification of Novel High Quality Methylated DNA Markers in Renal Tumors: Whole Methylome Discovery, Tissue Validation, and Feasibility Testing in Blood and Urine, the INQUIRE Study
This study is being done to collect blood, tissue and urine samples to identify a novel high quality methylated DNA marker in patients with renal tumors.
PRIMARY OBJECTIVES:
I. In tissue, to discover and validate DNA methylation markers (MDMs) for detection of malignant renal and urothelial tumors.
II. In blood, to assess the accuracy of candidate MDMs from above for detection of malignant renal and urothelial tumors.
OUTLINE: This is an observational study.
Participants may undergo blood, urine, and tissue sample collection on study. Participants' medical records are also reviewed.
Eligibility
Relevant conditions:
Chromophobe Renal Cell Carcinoma
Clear Cell Papillary Renal Tumor
Clear Cell Renal Cell Carcinoma
Kidney Oncocytoma
Papillary Renal Cell Carcinoma
Urothelial Carcinoma
If you aren't sure if you meet the criteria above speak to your healthcare professional. Criteria may be updated but not reflected here, do not hesitate to contact the trial if you think are close to fitting criteria.
locations
Contact Information
Overall Contact
No valid contacts available
Data sourced from ClinicalTrials.gov